💡 Very insightful article on securing the right mix of funding sources for #biotech startups. 🚀 "The journey to funding a startup in the biotech industry is long and it is not only about the funds but also about the added value investors can bring to your company. The adequate combination of sources vastly depends on your business model but governmental grants and subsidies in addition to VC investments seem to be the way to go in the industry as companies are dealing with long timelines and are rarely able to generate revenue early on."
How to navigate the biotech funding landscape? 🚣 Funding a startup is challenging, and it can be even trickier in the biotech industry. While it seems that biotech funding is in recovery, venture capital (VC) investment is still cautious and tends to go for de-risk opportunities. 💸 It is a good thing that’s not the only option for startups! While VC remains essential startups need to rely on multiple sources throughout their journey: grants, corporate venture capital, partnerships, debt financing… We reached out to experts to see clearer in this sometimes opaque environment. 🧭 Find out what they told us in our latest article! ⬇️ https://lnkd.in/dtWt6vTH #biotechfunding #startupchallenges #venturecapital #biotechstartups #grants #partnerships #biotechindustry #healthcareinnovation #startupfunding Kathleen Lee | Greater Phoenix Economic Council | Jörg Klumbis | Peptomyc | Katerina Stroponiati | Brilliant Minds | Michael Salako PhD MBA | Start Codon | Abveris | AngelList | Life Science Angels | TCA Venture Group
